Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals

BACKGROUND: The global pandemic of coronavirus disease 2019 (COVID-19) is caused by infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against SARS-CoV-2 in the USA, including two based on messenger RNA (mRNA) technology that has demonstrated high vaccine efficacy. We...

Full description

Saved in:
Bibliographic Details
Published in:BMC Med
Main Authors: Fraley, Elizabeth, LeMaster, Cas, Geanes, Eric, Banerjee, Dithi, Khanal, Santosh, Grundberg, Elin, Selvarangan, Rangaraj, Bradley, Todd
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310732/
https://ncbi.nlm.nih.gov/pubmed/34304742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-02055-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items